Ethan Barnett

1.3k total citations
16 papers, 416 citations indexed

About

Ethan Barnett is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Ethan Barnett has authored 16 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Ethan Barnett's work include Prostate Cancer Treatment and Research (14 papers), Cancer Genomics and Diagnostics (7 papers) and PARP inhibition in cancer therapy (4 papers). Ethan Barnett is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Cancer Genomics and Diagnostics (7 papers) and PARP inhibition in cancer therapy (4 papers). Ethan Barnett collaborates with scholars based in United States, Ireland and United Kingdom. Ethan Barnett's co-authors include Howard I. Scher, Emily Carbone, Melanie Hullings, Andreas G. Wibmer, Konrad H. Stopsack, Wassim Abida, David B. Solit, Bastien Nguyen, Nikolaus Schultz and Michael J. Morris and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Ethan Barnett

14 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ethan Barnett United States 8 291 185 183 144 39 16 416
Andrea E. Doak United States 6 253 0.9× 128 0.7× 200 1.1× 161 1.1× 29 0.7× 7 350
Mariangela Zanghì Italy 7 211 0.7× 79 0.4× 234 1.3× 144 1.0× 40 1.0× 12 414
Guowen Lin China 13 224 0.8× 162 0.9× 132 0.7× 207 1.4× 50 1.3× 20 466
Marcin Nicoś Poland 11 164 0.6× 157 0.8× 170 0.9× 191 1.3× 39 1.0× 43 417
Mai N. Van Netherlands 7 259 0.9× 182 1.0× 165 0.9× 88 0.6× 68 1.7× 13 361
Jae Sook Sung South Korea 13 173 0.6× 194 1.0× 194 1.1× 239 1.7× 16 0.4× 31 436
Lyndsey Dugan United States 6 265 0.9× 230 1.2× 250 1.4× 89 0.6× 33 0.8× 14 424
Nicolas Kiavué France 10 110 0.4× 179 1.0× 257 1.4× 110 0.8× 36 0.9× 13 363
Rachel Krupa United States 8 266 0.9× 250 1.4× 320 1.7× 108 0.8× 40 1.0× 26 469
Anuradha Jayaram United Kingdom 7 332 1.1× 263 1.4× 108 0.6× 128 0.9× 69 1.8× 24 427

Countries citing papers authored by Ethan Barnett

Since Specialization
Citations

This map shows the geographic impact of Ethan Barnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Barnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Barnett more than expected).

Fields of papers citing papers by Ethan Barnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan Barnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Barnett. The network helps show where Ethan Barnett may publish in the future.

Co-authorship network of co-authors of Ethan Barnett

This figure shows the co-authorship network connecting the top 25 collaborators of Ethan Barnett. A scholar is included among the top collaborators of Ethan Barnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ethan Barnett. Ethan Barnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Moukarzel, Lea A., Jie Liu, Duc Tran, et al.. (2025). Investigation of clonal hematopoiesis frequency following PARP inhibitor treatment and its association with prior platinum therapy exposure.. Journal of Clinical Oncology. 43(16_suppl).
2.
Barnett, Ethan, Nikolaus Schultz, Konrad H. Stopsack, et al.. (2022). Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer. European Urology. 83(2). 112–120. 10 indexed citations
3.
Keegan, Niamh M., Ethan Barnett, Emily Carbone, et al.. (2022). Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality. The Prostate. 82(11). 1107–1116. 4 indexed citations
4.
Mathur, Deepti, Ethan Barnett, Howard I. Scher, & João B. Xavier. (2022). Optimizing the future: how mathematical models inform treatment schedules for cancer. Trends in cancer. 8(6). 506–516. 24 indexed citations
5.
Barnett, Ethan, et al.. (2022). Genomic alterations and evolution in patients with prostate cancer with histologic evidence of neuroendocrine differentiation.. Journal of Clinical Oncology. 40(16_suppl). 5029–5029. 1 indexed citations
6.
Scher, Howard I., Katherine Cunningham, Ethan Barnett, et al.. (2021). Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.. Journal of Clinical Oncology. 39(15_suppl). e17039–e17039. 3 indexed citations
7.
Stopsack, Konrad H., Subhiksha Nandakumar, Andreas G. Wibmer, et al.. (2020). Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 26(13). 3230–3238. 119 indexed citations
8.
Lu, David, Rachel Krupa, Melissa Harvey, et al.. (2020). Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer. SHILAP Revista de lepidopterología. 9(1). 13–19. 8 indexed citations
9.
Barnett, Ethan, Joseph D. Schonhoft, Nikolaus Schultz, et al.. (2020). Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole genome sequencing of circulating tumor cells (CTCs) in castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 38(15_suppl). 5531–5531. 1 indexed citations
10.
Schonhoft, Joseph D., Jimmy L. Zhao, Adam Jendrisak, et al.. (2020). Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer. Cancer Research. 80(22). 4892–4903. 32 indexed citations
11.
Mota, José Maurício, Ethan Barnett, Jones T. Nauseef, et al.. (2020). Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations. JCO Precision Oncology. 4(4). 355–366. 98 indexed citations
12.
13.
Graf, Ryon P., Melanie Hullings, Ethan Barnett, et al.. (2019). Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer. European Urology. 77(2). 170–177. 58 indexed citations
14.
Mota, José Maurício, Ethan Barnett, Jones T. Nauseef, et al.. (2019). Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes.. Journal of Clinical Oncology. 37(15_suppl). 5038–5038. 4 indexed citations
15.
16.
Ferrari, Anna C., Joshi J. Alumkal, Mark N. Stein, et al.. (2018). Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(1). 52–63. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea E. Doak Breakdown of academic impact, for papers by Mariangela Zanghì Breakdown of academic impact, for papers by Guowen Lin Breakdown of academic impact, for papers by Marcin Nicoś Breakdown of academic impact, for papers by Mai N. Van Breakdown of academic impact, for papers by Jae Sook Sung Breakdown of academic impact, for papers by Lyndsey Dugan Breakdown of academic impact, for papers by Nicolas Kiavué Breakdown of academic impact, for papers by Rachel Krupa Breakdown of academic impact, for papers by Anuradha Jayaram
Rankless by CCL
2026